{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T19:21:12Z","timestamp":1793906472033,"version":"4.8.0"},"publisher-location":"Cham","reference-count":28,"publisher":"Springer Nature Switzerland","isbn-type":[{"value":"9783031765490","type":"print"},{"value":"9783031765506","type":"electronic"}],"license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025]]},"DOI":"10.1007\/978-3-031-76550-6_21","type":"book-chapter","created":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T20:47:12Z","timestamp":1739220432000},"page":"127-131","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Current Perspectives of TLR2 Signalling in the Retina"],"prefix":"10.1007","author":[{"given":"Rachel","family":"Dalton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Doyle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,11]]},"reference":[{"key":"21_CR1","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.3389\/fphar.2018.01280","volume":"9","author":"I Bellezza","year":"2018","unstructured":"Bellezza I. Oxidative stress in age-related macular degeneration: Nrf2 as therapeutic target. Front Pharmacol. 2018;9:1280.","journal-title":"Front Pharmacol"},{"key":"21_CR2","doi-asserted-by":"publisher","first-page":"417","DOI":"10.3389\/fphar.2018.00417","volume":"9","author":"IF Caplan","year":"2018","unstructured":"Caplan IF, Maguire-Zeiss KA. Toll-like receptor 2 signaling and current approaches for therapeutic modulation in synucleinopathies. Front Pharmacol. 2018;9:417.","journal-title":"Front Pharmacol"},{"key":"21_CR3","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1038\/nri2873","volume":"10","author":"GY Chen","year":"2010","unstructured":"Chen GY, Nu\u00f1ez G. Sterile inflammation: sensing and reacting to damage. Nat Rev Immunol. 2010;10:826\u201337.","journal-title":"Nat Rev Immunol"},{"key":"21_CR4","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1084\/jem.20031237","volume":"199","author":"SE Doyle","year":"2004","unstructured":"Doyle SE, O\u2019Connell RM, Miranda GA, et al. Toll-like receptors induce a phagocytic gene program through p38. J Exp Med. 2004;199:81\u201390.","journal-title":"J Exp Med"},{"key":"21_CR5","doi-asserted-by":"publisher","first-page":"2208","DOI":"10.1016\/j.ajpath.2017.06.015","volume":"187","author":"L Feng","year":"2017","unstructured":"Feng L, Ju M, Lee KYV, et al. A proinflammatory function of toll-like receptor 2 in the retinal pigment epithelium as a novel target for reducing choroidal neovascularization in age-related macular degeneration. Am J Pathol. 2017;187:2208\u201321.","journal-title":"Am J Pathol"},{"key":"21_CR6","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/978-3-319-17121-0_8","volume":"854","author":"R Fernandez-Godino","year":"2016","unstructured":"Fernandez-Godino R, Pierce EA, Garland DL. Extracellular matrix alterations and deposit formation in AMD. Adv Exp Med Biol. 2016;854:53\u20138.","journal-title":"Adv Exp Med Biol"},{"key":"21_CR7","doi-asserted-by":"publisher","first-page":"4694","DOI":"10.1167\/iovs.09-4464","volume":"51","author":"T Fujimoto","year":"2010","unstructured":"Fujimoto T, Sonoda KH, Hijioka K, et al. Choroidal neovascularization enhanced by Chlamydia pneumoniae via Toll-like receptor 2 in the retinal pigment epithelium. Invest Ophthalmol Vis Sci. 2010;51:4694\u2013702.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"21_CR8","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1124\/pr.114.010090","volume":"68","author":"S Goulopoulou","year":"2016","unstructured":"Goulopoulou S, McCarthy CG, Webb RC. Toll-like receptors in the vascular system: sensing the dangers within. Pharmacol Rev. 2016;68:142\u201367.","journal-title":"Pharmacol Rev"},{"key":"21_CR9","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1126\/science.270.5239.1189","volume":"270","author":"TS Griffith","year":"1995","unstructured":"Griffith TS, Brunner T, Fletcher SM, et al. Fas ligand-induced apoptosis as a mechanism of immune privilege. Science. 1995;270:1189\u201392.","journal-title":"Science"},{"key":"21_CR10","doi-asserted-by":"publisher","first-page":"27739","DOI":"10.1038\/srep27739","volume":"6","author":"C He","year":"2016","unstructured":"He C, Lai P, Wang J, et al. TLR2\/4 deficiency prevents oxygen-induced vascular degeneration and promotes revascularization by downregulating IL-17 in the retina. Sci Rep. 2016;6:27739.","journal-title":"Sci Rep"},{"key":"21_CR11","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1038\/ni1004-971","volume":"5","author":"K Hoebe","year":"2004","unstructured":"Hoebe K, Janssen E, Beutler B. The interface between innate and adaptive immunity. Nat Immunol. 2004;5:971\u20134.","journal-title":"Nat Immunol"},{"key":"21_CR12","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.ejphar.2016.04.024","volume":"785","author":"DH Hwang","year":"2016","unstructured":"Hwang DH, Kim JA, Lee JY. Mechanisms for the activation of Toll-like receptor 2\/4 by saturated fatty acids and inhibition by docosahexaenoic acid. Eur J Pharmacol. 2016;785:24\u201335.","journal-title":"Eur J Pharmacol"},{"key":"21_CR13","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.exer.2019.05.006","volume":"184","author":"R Kumar-Singh","year":"2019","unstructured":"Kumar-Singh R. The role of complement membrane attack complex in dry and wet AMD \u2013 from hypothesis to clinical trials. Exp Eye Res. 2019;184:266\u201377.","journal-title":"Exp Eye Res"},{"key":"21_CR14","doi-asserted-by":"publisher","first-page":"211","DOI":"10.15252\/emmm.201404524","volume":"7","author":"O Levy","year":"2015","unstructured":"Levy O, Calippe B, Lavalette S, et al. Apolipoprotein E promotes subretinal mononuclear phagocyte survival and chronic inflammation in age-related macular degeneration. EMBO Mol Med. 2015;7:211\u201326.","journal-title":"EMBO Mol Med"},{"key":"21_CR15","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1038\/nature09121","volume":"465","author":"SC Lin","year":"2010","unstructured":"Lin SC, Lo YC, Wu H. Helical assembly in the MyD88-IRAK4-IRAK2 complex in TLR\/IL-1R signalling. Nature. 2010;465:885\u201390.","journal-title":"Nature"},{"key":"21_CR16","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1016\/j.celrep.2020.01.064","volume":"30","author":"K Mulfaul","year":"2020","unstructured":"Mulfaul K, Ozaki E, Fernando N, et al. Toll-like receptor 2 facilitates oxidative damage-induced retinal degeneration. Cell Rep. 2020;30:2209\u20132224.e2205.","journal-title":"Cell Rep"},{"key":"21_CR17","doi-asserted-by":"publisher","first-page":"3709","DOI":"10.1167\/iovs.14-13989","volume":"55","author":"N Nagai","year":"2014","unstructured":"Nagai N, Lundh von Leithner P, Izumi-Nagai K, et al. Spontaneous CNV in a novel mutant mouse is associated with early VEGF-A-driven angiogenesis and late-stage focal edema, neural cell loss, and dysfunction. Invest Ophthalmol Vis Sci. 2014;55:3709\u201319.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"21_CR18","doi-asserted-by":"publisher","first-page":"79","DOI":"10.3389\/fimmu.2012.00079","volume":"3","author":"L Oliveira-Nascimento","year":"2012","unstructured":"Oliveira-Nascimento L, Massari P, Wetzler LM. The role of TLR2 in infection and immunity. Front Immunol. 2012;3:79.","journal-title":"Front Immunol"},{"key":"21_CR19","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1155\/2010\/672395","volume":"2010","author":"AM Piccinini","year":"2010","unstructured":"Piccinini AM, Midwood KS. DAMPening inflammation by modulating TLR signalling. Mediat Inflamm. 2010;2010:2\u201321.","journal-title":"Mediat Inflamm"},{"key":"21_CR20","doi-asserted-by":"publisher","first-page":"2","DOI":"10.3390\/cells9092057","volume":"9","author":"FA Rossato","year":"2020","unstructured":"Rossato FA, Su Y, Mackey A, et al. Fibrotic changes and endothelial-to-mesenchymal transition promoted by VEGFR2 antagonism alter the therapeutic effects of vegfa pathway blockage in a mouse model of choroidal neovascularization. Cells. 2020;9:2\u201321.","journal-title":"Cells"},{"key":"21_CR21","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.exer.2014.08.011","volume":"133","author":"S Roy","year":"2015","unstructured":"Roy S, Bae E, Amin S, et al. Extracellular matrix, gap junctions, and retinal vascular homeostasis in diabetic retinopathy. Exp Eye Res. 2015;133:58\u201368.","journal-title":"Exp Eye Res"},{"key":"21_CR22","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1002\/emmm.201302692","volume":"5","author":"F Sennlaub","year":"2013","unstructured":"Sennlaub F, Auvynet C, Calippe B, et al. CCR2(+) monocytes infiltrate atrophic lesions in age-related macular disease and mediate photoreceptor degeneration in experimental subretinal inflammation in Cx3cr1 deficient mice. EMBO Mol Med. 2013;5:1775\u201393.","journal-title":"EMBO Mol Med"},{"key":"21_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2021.108716","volume":"210","author":"Y Sun","year":"2021","unstructured":"Sun Y, Ni Y, Kong N, et al. TLR2 signaling contributes to the angiogenesis of oxygen-induced retinopathy. Exp Eye Res. 2021;210:108716.","journal-title":"Exp Eye Res"},{"key":"21_CR24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0068871","volume":"8","author":"J Tang","year":"2013","unstructured":"Tang J, Allen Lee C, Du Y, et al. MyD88-dependent pathways in leukocytes affect the retina in diabetes. PLoS One. 2013;8:e68871.","journal-title":"PLoS One"},{"key":"21_CR25","doi-asserted-by":"publisher","first-page":"9193","DOI":"10.1038\/s41598-017-09451-3","volume":"7","author":"JW Wang","year":"2017","unstructured":"Wang JW, Fontes MSC, Wang X, et al. Leukocytic toll-like receptor 2 deficiency preserves cardiac function and reduces fibrosis in sustained pressure overload. Sci Rep. 2017;7:9193.","journal-title":"Sci Rep"},{"key":"21_CR26","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1038\/nature09421","volume":"467","author":"XZ West","year":"2010","unstructured":"West XZ, Malinin NL, Merkulova AA, et al. Oxidative stress induces angiogenesis by activating TLR2 with novel endogenous ligands. Nature. 2010;467:972\u20136.","journal-title":"Nature"},{"key":"21_CR27","first-page":"6807","volume":"8","author":"Y Yu","year":"2015","unstructured":"Yu Y, Yang L, Lv J, et al. The role of high mobility group box 1 (HMGB-1) in the diabetic retinopathy inflammation and apoptosis. Int J Clin Exp Pathol. 2015;8:6807\u201313.","journal-title":"Int J Clin Exp Pathol"},{"key":"21_CR28","first-page":"2","volume":"15","author":"M Zhao","year":"2016","unstructured":"Zhao M, Li CH, Liu YL. Toll-like receptor (TLR)-2\/4 expression in retinal ganglion cells in a high-glucose environment and its implications. Genet Mol Res. 2016;15:2\u20138.","journal-title":"Genet Mol Res"}],"container-title":["Advances in Experimental Medicine and Biology","Retinal Degenerative Diseases XX"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-031-76550-6_21","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T20:47:14Z","timestamp":1739220434000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-031-76550-6_21"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"ISBN":["9783031765490","9783031765506"],"references-count":28,"URL":"https:\/\/doi.org\/10.1007\/978-3-031-76550-6_21","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]},"assertion":[{"value":"11 February 2025","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}},{"value":"IWAAL","order":1,"name":"conference_acronym","label":"Conference Acronym","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"International Workshop on Ambient Assisted Living","order":2,"name":"conference_name","label":"Conference Name","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"Torremolinos","order":3,"name":"conference_city","label":"Conference City","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"Spain","order":4,"name":"conference_country","label":"Conference Country","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"2011","order":5,"name":"conference_year","label":"Conference Year","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"8 June 2011","order":7,"name":"conference_start_date","label":"Conference Start Date","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"10 June 2011","order":8,"name":"conference_end_date","label":"Conference End Date","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"3","order":9,"name":"conference_number","label":"Conference Number","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"7215","order":10,"name":"conference_id","label":"Conference ID","group":{"name":"ConferenceInfo","label":"Conference Information"}}]}}